224 related articles for article (PubMed ID: 31882554)
21. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.
Su K; Zhang T; Wang Y; Hao G
World J Surg Oncol; 2016 Aug; 14(1):224. PubMed ID: 27733164
[TBL] [Abstract][Full Text] [Related]
22. Single tube liquid biopsy for advanced non-small cell lung cancer.
de Wit S; Rossi E; Weber S; Tamminga M; Manicone M; Swennenhuis JF; Groothuis-Oudshoorn CGM; Vidotto R; Facchinetti A; Zeune LL; Schuuring E; Zamarchi R; Hiltermann TJN; Speicher MR; Heitzer E; Terstappen LWMM; Groen HJM
Int J Cancer; 2019 Jun; 144(12):3127-3137. PubMed ID: 30536653
[TBL] [Abstract][Full Text] [Related]
23. Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohorts.
Buhl IK; Santoni-Rugiu E; Ravn J; Hansen A; Christensen IJ; Jensen T; Pratt B; Askaa J; Jensen PB; Knudsen S; Sørensen JB
PLoS One; 2018; 13(3):e0194609. PubMed ID: 29566065
[TBL] [Abstract][Full Text] [Related]
24. Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.
Villaflor V; Won B; Nagy R; Banks K; Lanman RB; Talasaz A; Salgia R
Oncotarget; 2016 Oct; 7(41):66880-66891. PubMed ID: 27602770
[TBL] [Abstract][Full Text] [Related]
25. The diagnostic value of circulating stanniocalcin-1 mRNA in non-small cell lung cancer.
Du YZ; Gu XH; Li L; Gao F
J Surg Oncol; 2011 Dec; 104(7):836-40. PubMed ID: 21656524
[TBL] [Abstract][Full Text] [Related]
26. Liquid Biopsy and Lung Cancer.
Pisapia P; Malapelle U; Troncone G
Acta Cytol; 2019; 63(6):489-496. PubMed ID: 30566947
[TBL] [Abstract][Full Text] [Related]
27. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C
Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916
[TBL] [Abstract][Full Text] [Related]
29. Aberrant expression of HIF3A in plasma of patients with non-small cell lung cancer and its clinical significance.
Wei L; Yuan N; Chen Y; Gong P
J Clin Lab Anal; 2021 Aug; 35(8):e23889. PubMed ID: 34245041
[TBL] [Abstract][Full Text] [Related]
30. Clinical Significance of Circulatory miRNA-21 as an Efficient Non-Invasive Biomarker for the Screening of Lung Cancer Patients.
Abu-Duhier FM; Javid J; Sughayer MA; Mir R; Albalawi T; Alauddin MS
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2607-2611. PubMed ID: 30256067
[TBL] [Abstract][Full Text] [Related]
31. Serum APE1 as a predictive marker for platinum-based chemotherapy of non-small cell lung cancer patients.
Zhang S; He L; Dai N; Guan W; Shan J; Yang X; Zhong Z; Qing Y; Jin F; Chen C; Yang Y; Wang H; Baugh L; Tell G; Wilson DM; Li M; Wang D
Oncotarget; 2016 Nov; 7(47):77482-77494. PubMed ID: 27813497
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
33. Circulating Messenger RNA Profiling with Microarray and Next-generation Sequencing: Cross-platform Comparison.
Shih CL; Luo JD; Chang JW; Chen TL; Chien YT; Yu CJ; Chiou CC
Cancer Genomics Proteomics; 2015; 12(5):223-30. PubMed ID: 26417025
[TBL] [Abstract][Full Text] [Related]
34. Increased Plasma miRNA-30a as a Biomarker for Non-Small Cell Lung Cancer.
Sun L; Chen Y; Su Q; Tang X; Liang Y; Che G; Luo F
Med Sci Monit; 2016 Feb; 22():647-55. PubMed ID: 26918265
[TBL] [Abstract][Full Text] [Related]
35. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
[TBL] [Abstract][Full Text] [Related]
36. Molecular detection and prognostic value of epithelial markers mRNA expression in peripheral blood of advanced non-small cell lung cancer patients.
Arrieta O; Pineda B; Muñiz-Hernández S; Flores D; Ordóñez G; Borbolla-Escoboza JR; Orta D
Cancer Biomark; 2014; 14(4):215-23. PubMed ID: 24934364
[TBL] [Abstract][Full Text] [Related]
37. circIARS: a potential plasma biomarker for diagnosing non-small cell lung cancer.
Zhang Q; Fan X; Zhang X; Ju S
Acta Biochim Biophys Sin (Shanghai); 2024 Jun; 56(6):927-936. PubMed ID: 38686459
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of serum miR-25 in non-small-cell lung cancer.
Li J; Yu M; Liu Z; Liu B
Br J Biomed Sci; 2019 Jul; 76(3):111-116. PubMed ID: 30919763
[No Abstract] [Full Text] [Related]
39. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer.
Kanaoka R; Iinuma H; Dejima H; Sakai T; Uehara H; Matsutani N; Kawamura M
Oncology; 2018; 94(5):311-323. PubMed ID: 29533963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
